Cargando…

MAFLD associated with COPD via systemic inflammation independent of aging and smoking in men

BACKGROUND AND AIM: Metabolic dysfunction and associated systemic inflammation are risk factors for chronic obstructive pulmonary disease (COPD) and COPD is highly prevalent in men. We investigated the impact of metabolic-associated fatty liver disease (MAFLD) and MAFLD-related systemic inflammation...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tsutsumi, Tsubasa, Nakano, Dan, Kawaguchi, Machiko, Hashida, Ryuki, Yoshinaga, Shinobu, Takahashi, Hirokazu, Anzai, Keizo, Kawaguchi, Takumi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9380323/ https://www.ncbi.nlm.nih.gov/pubmed/35974418 http://dx.doi.org/10.1186/s13098-022-00887-w

Ejemplares similares

The Inter-Organ Crosstalk Reveals an Inevitable Link between MAFLD and Extrahepatic Diseases
por: Tsutsumi, Tsubasa, et al.
Publicado: (2023)

MAFLD enhances clinical practice for liver disease in the Asia-Pacific region
por: Kawaguchi, Takumi, et al.
Publicado: (2022)

Association between Activity and Brain-Derived Neurotrophic Factor in Patients with Non-Alcoholic Fatty Liver Disease: A Data-Mining Analysis
por: Hashida, Ryuki, et al.
Publicado: (2021)

A low‐intensity 10‐min resistance exercise program that ameliorated hepatic fibrosis indices and altered G‐CSF/IP‐10/PDGF‐BB in a patient with nonalcoholic fatty liver disease: A case report
por: Hashida, Ryuki, et al.
Publicado: (2023)

Hepatic expression of sodium–glucose cotransporter 2 (SGLT2) in patients with chronic liver disease
por: Nakano, Dan, et al.
Publicado: (2022)

Effects of interleukin-17 inhibitors on hepatic fibrosis index in patients with psoriasis and metabolic dysfunction-associated fatty liver disease: Directed acyclic graphs
por: Takamura, Saori, et al.
Publicado: (2022)

Effects of In-Hospital Physical Therapy on Activities of Daily Living in Patients with Hepatocellular Carcinoma
por: Narao, Hayato, et al.
Publicado: (2020)

Effects of In-Hospital Exercise on Frailty in Patients with Hepatocellular Carcinoma
por: Tsuchihashi, Jin, et al.
Publicado: (2021)

Non-Obese MAFLD Is Associated with Colorectal Adenoma in Health Check Examinees: A Multicenter Retrospective Study
por: Fukunaga, Shuhei, et al.
Publicado: (2021)

Effects of SGLT2 inhibitor on tumor‐releasing chemokines/cytokines in Hep3B and Huh7 cells
por: Nakano, Dan, et al.
Publicado: (2022)

Impact of Decorin on the Physical Function and Prognosis of Patients with Hepatocellular Carcinoma
por: Kawaguchi, Takumi, et al.
Publicado: (2020)

Impact of cancer rehabilitation on the prognosis of patients with hepatocellular carcinoma
por: Hashida, Ryuki, et al.
Publicado: (2020)

Editorial: The Metabolic (Dysfunction) Associated Fatty Liver Disease (MAFLD)-Non-Alcoholic Fatty Liver Disease (NAFLD) Debate: A Forced Consensus and The Risk of a World Divide
por: Méndez-Sánchez, Nahum, et al.
Publicado: (2022)

Reply to the Letter to the editor “Ipragliflozin improves the hepatic outcomes of patients with diabetes with NAFLD”
por: Takahashi, Hirokazu, et al.
Publicado: (2022)

Furthering research on MAFLD: the APASL Metabolic fAtty lIver DiseasE coNsortium (MAIDEN)
por: George, Jacob, et al.
Publicado: (2023)

Prevalence and profiles of ramucirumab-associated severe ascites in patients with hepatocellular carcinoma
por: Kamachi, Naoki, et al.
Publicado: (2021)

Comparison of the role of alcohol consumption and qualitative abdominal fat on NAFLD and MAFLD in males and females
por: Sogabe, Masahiro, et al.
Publicado: (2022)

Role of Insulin Resistance in MAFLD
por: Sakurai, Yoshitaka, et al.
Publicado: (2021)

The Gut Microbiome and Ferroptosis in MAFLD
por: Ji, Jie, et al.
Publicado: (2023)

MAFLD: a multisystem disease
por: Pipitone, Rosaria Maria, et al.
Publicado: (2023)

NAFLD/MAFLD: New Evidence
por: Mantovani, Alessandro, et al.
Publicado: (2023)

Editorial: The NAFLD-MAFLD conundrum
por: Dalbeni, Andrea, et al.
Publicado: (2023)

MAFLD and Celiac Disease in Children
por: Scapaticci, Serena, et al.
Publicado: (2023)

Behavioral defects and downregulation of hippocampal BDNF and nNOS expression in db/db mice did not improved by chronic TGF-β2 treatment
por: Tomiga, Yuki, et al.
Publicado: (2022)

Phenotypic Characterization by Single-Cell Mass Cytometry of Human Intrahepatic and Peripheral NK Cells in Patients with Hepatocellular Carcinoma
por: Yoshida, Yuichi, et al.
Publicado: (2021)

Inflammation and Fibrogenesis in MAFLD: Role of the Hepatic Immune System
por: Torre, Pietro, et al.
Publicado: (2021)

TLR9 in MAFLD and NASH: At the Intersection of Inflammation and Metabolism
por: Shepard, Christopher R.
Publicado: (2021)

MAFLD and CKD: An Updated Narrative Review
por: Mantovani, Alessandro, et al.
Publicado: (2022)

Emerging pharmacological treatment options for MAFLD
por: Rojas, Ángela, et al.
Publicado: (2022)

MAFLD: How is it different from NAFLD?
por: Gofton, Cameron, et al.
Publicado: (2023)

Comparison of MAFLD and NAFLD Characteristics in Children
por: Xing, Yunfei, et al.
Publicado: (2023)

Screening for MAFLD: who, when and how?
por: Pal, Shreya C., et al.
Publicado: (2023)

Sarcopenia is associated with cardiovascular risk in men with COPD, independent of adiposity
por: Leem, Ah Young, et al.
Publicado: (2022)

Prediction of Nonalcoholic Fatty Liver Disease Using Noninvasive and Non-Imaging Procedures in Japanese Health Checkup Examinees
por: Murayama, Kenichiro, et al.
Publicado: (2021)

Efficacy of pegylated interferon plus ribavirin in combination with corticosteroid for two cases of combined hepatitis C and autoimmune hepatitis
por: Oeda, Satoshi, et al.
Publicado: (2012)

Therapeutic Approaches to Nonalcoholic Fatty Liver Disease: Exercise Intervention and Related Mechanisms
por: Takahashi, Hirokazu, et al.
Publicado: (2018)

SARS-CoV-2 Infection and Pancreatic β Cell Failure
por: Mine, Keiichiro, et al.
Publicado: (2021)

Isoflavone Aglycones Attenuate Cigarette Smoke-Induced Emphysema via Suppression of Neutrophilic Inflammation in a COPD Murine Model
por: Kojima, Kazuya, et al.
Publicado: (2019)

The sputum microbiome is distinct between COPD and health, independent of smoking history
por: Haldar, Koirobi, et al.
Publicado: (2020)

MAFLD in Obese Children: A Challenging Definition
por: Di Sessa, Anna, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_446p789uch9j13a39gusogp4sn